More than 600,000 women die of advanced breast cancer annually. (1) There is a safe, universally obtainable method to reduce this terrible toll according to MammaCare Foundation scientist Mark Kane Goldstein, Ph.D.

Module 1


October 15, 2020 — More than 600,000 women die of advanced breast cancer annually. (1) There is a safe, universally obtainable method to reduce this terrible toll according to MammaCare Foundation scientist Mark Kane Goldstein, Ph.D.: "By producing more skilled hands everywhere," he reported. 

Scientific and clinical evidence indicate that properly trained hands can detect small, suspicious, breast tumors before they advance to late, untreatable malignancies. (2) Although breast exams are performed widely, they are not performed well without training and practice. Recognizing the work of renowned inventor Louis Braille who calibrated fingers to read tiny raised dots, MammaCare scientists applied Braille's principles to breast exams by calibrating the sense of touch to the detection of sub-centimeter tumors in complex breast tissues.

With the support of the National Science Foundation, MammaCare created a breast exam training platform and program that works anywhere while connected to Google Chrome's internet browser. Exam performance is converted into a data stream that can be reviewed by instructors who are given remote access.

The portable devices interact with and guide practitioners and students performance while monitoring and shaping their clinical exam skills on connected, tactually accurate, breast models until they reliably detect all suspicious, pea-sized (<0.5cm) tumors present. False positives are reduced by learning to feel and confirm the difference between tumors and normal, lumpy breast tissues also present in the models.   

MammaCare deployed the first version of the technology for the Women Veterans Health Program and is now equipping U.S. colleges of nursing and medicine, as well as  Congressionally-sponsored National Breast and Cervical Cancer Early Detection Programs (NBCCEDP).(3) (4) (5) 

The worldwide need for skilled hands is demonstrated in MalaysiaAfricaUSIndiaQatar/ PakistanCanada, Goldstein reported, adding that "reproducible, inexpensive technology now allows us to reach out within and across continents to calibrate and validate the essential exam skills of local nurses and practitioners for early detection, helping thereby to bring down the massive global burden of advanced, late stage breast cancer." (6)(7)(8)(9)(10)(11)

For more information: www.mammacare.org

 


Related Content

News | Women's Health

Dec. 12. 2025 — A new study has found that an individualized approach to breast cancer screening that assesses patients’ ...

Time December 17, 2025
arrow
News | Breast Imaging

Dec. 16, 2025 — Hologic, Inc, a medical technology company dedicated to improving women’s health, recently announced new ...

Time December 16, 2025
arrow
News | Artificial Intelligence

Dec. 1, 2025 — Researchers at the University of California, Berkeley and University of California, San Francisco have ...

Time December 10, 2025
arrow
News | FDA

Dec. 8, 2025 — Lunit, a provider of AI for cancer diagnostics and precision oncology, has submitted a 510(k) premarket ...

Time December 08, 2025
arrow
News | Breast Imaging

Dec. 01, 2025 — DeepHealth, a wholly owned subsidiary of RadNet, Inc., has launched the DeepHealth Breast Suite,2 an end ...

Time December 04, 2025
arrow
News | Women's Health

Dec. 1, 2025 — ScreenPoint Medical has completed a commercial agreement making its Transpara breast-imaging AI portfolio ...

Time December 03, 2025
arrow
News | Mammography

Nov. 30, 2025 — At RSNA 2025, Siemens Healthineers will introduce new capabilities for its Mammomat B.brilliant ...

Time December 02, 2025
arrow
News | RSNA 2025

Dec. 2, 2025 — Lunit, a provider of AI for cancer diagnostics and precision oncology, will present 14 studies at RSNA ...

Time December 02, 2025
arrow
News | Women's Health

Dec. 1, 2025 — A study of data from seven outpatient facilities in the New York region found that 20-24% of all the ...

Time December 02, 2025
arrow
News | Mammography

Nov. 26, 2025 — GE HealthCare has announced it received FDA Premarket Authorization for Pristina Recon DL, an advanced ...

Time November 29, 2025
arrow
Subscribe Now